background
interspeci
interact
nasopharyng
microbiota
like
involv
pathogenesi
acut
otiti
media
aom
captur
breadth
microbi
interact
requir
detail
descript
microbiota
health
aom
method
nasopharyng
microbiota
infant
n
without
n
aom
character
use
nasopharyng
swab
multiplex
pyrosequenc
rrna
nasopharyng
swab
specimen
collect
winter
season
infant
aom
control
result
fiftyeight
bacteri
famili
identifi
moraxellacea
streptococcacea
pasteurellacea
frequent
commens
famili
less
preval
infant
aom
control
infant
aom
prior
exposur
antimicrobi
administr
heptaval
conjug
pneumococc
polysaccharid
vaccin
also
associ
reduc
preval
distinct
commens
famili
streptococcacea
corynebacteriacea
addit
antimicrobi
exposur
increas
preval
enterobacteriacea
abund
pasteurellacea
factor
age
sex
day
care
histori
recurr
aom
influenc
microbiota
conclus
infant
nasopharyng
microbiota
undergo
signific
chang
aom
exposur
antimicrobi
mainli
attribut
reduc
preval
commens
bacteri
famili
acut
otiti
media
aom
one
common
pediatr
infecti
diseas
worldwid
major
reason
antibiot
prescript
children
develop
countri
main
pathogen
associ
aom
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
human
nasopharynx
primari
site
colon
pathogen
start
point
ascend
middl
ear
numer
bacteri
virul
factor
identifi
strategi
use
pathogen
evad
host
defens
mechan
studi
less
known
role
microbi
commun
structur
interspeci
interact
pathogenesi
aom
evid
interspeci
crosstalk
recent
demonstr
influenc
heptaval
conjug
pneumococc
polysaccharid
vaccin
colon
preval
aom
pathogen
h
influenza
catarrhali
staphylococcu
aureu
captur
breadth
interspeci
interplay
detail
descript
microbiota
healthi
diseas
stage
requir
convent
cultur
limit
valu
purpos
mani
bacteria
colon
human
cultur
signific
develop
appli
culturalindepend
method
character
microbi
commun
differ
human
bodi
habitat
includ
shotgun
sequenc
whole
metagenom
amplicon
sequenc
select
phylogenet
marker
recent
studi
microbi
commun
upper
respiratori
tract
children
without
aom
describ
studi
includ
children
wide
age
rang
span
month
year
base
sampl
taken
nostril
studi
present
focus
narrow
age
rang
infant
year
appli
pyrosequenc
rrna
gene
amplicon
nasopharyng
swab
np
specimen
infant
aom
control
infant
studi
period
span
year
introduct
switzerland
main
research
aim
character
microbiota
infant
aom
compar
control
infant
addit
studi
influenc
recent
antimicrobi
exposur
administr
nasopharyng
microbiota
infant
aom
data
serv
basi
studi
role
nasopharyng
microbiota
pathogenesi
aom
np
specimen
collect
ongo
nationwid
surveil
program
consecut
infant
year
age
present
aom
outpati
practic
data
age
sex
place
resid
antimicrobi
treatment
previou
week
number
aom
episod
previou
month
current
use
day
care
vaccin
obtain
time
sampl
collect
switzerland
ad
routin
vaccin
schedul
therefor
season
design
prevaccin
season
tabl
total
np
specimen
collect
studi
period
select
studi
twentyf
np
specimen
exclud
suffici
dna
lack
clinic
inform
respect
addit
infant
aom
np
specimen
collect
infant
without
aom
seen
variou
reason
outpati
clinic
univers
hospit
bern
tabl
diagnos
control
infant
seen
surgeri
lingual
frenulum
infant
lymphangioma
neck
infant
six
infant
part
human
immunodefici
viru
hiv
hepat
c
viru
exposur
studi
group
respect
hiv
hepat
c
viru
neg
final
infant
present
clinic
repeat
skin
abscess
underli
morbid
identifi
approv
local
ethic
committe
inform
consent
obtain
collect
sampl
control
surveil
program
part
government
public
health
surveil
exempt
approv
institut
review
board
handl
swab
dna
extract
previous
describ
everi
sampl
includ
neg
mock
control
extract
protocol
perform
ident
manner
sampl
region
bacteri
rrna
gene
amplifi
use
primer
pair
primer
sequenc
modifi
addit
sequenc
adaptor
forward
b
revers
multiplex
identifi
supplementari
tabl
polymeras
chain
reaction
pcr
perform
total
volum
use
fast
start
taq
reaction
buffer
mm
final
magnesium
chlorid
mm
final
deoxyribonucleotid
triphosph
lm
final
forward
revers
fusion
primer
unit
fast
start
taq
polymeras
roch
extract
dna
pcr
cycl
condit
includ
minut
cycl
denatur
second
anneal
second
elong
minut
final
minut
pcr
product
purifi
use
wizard
sv
pcr
cleanup
system
promega
final
elut
step
perform
use
doubl
distil
water
sampl
pool
use
ng
pcr
product
sampl
result
differ
pool
includ
everi
multiplex
identifi
amplif
result
mock
control
consist
detect
level
could
therefor
ad
run
amplicon
librari
sequenc
accord
titanium
amplicon
sequenc
protocol
seri
qualiti
control
step
appli
result
read
supplementari
method
total
forward
revers
read
uniform
length
nucleotid
high
qualiti
retain
filter
submit
nation
center
biotechnolog
inform
sequenc
read
archiv
access
number
supplementari
tabl
pyrotagg
use
definit
oper
taxonom
unit
otu
base
sequenc
ident
estim
chimera
taxonomi
assign
supplementari
method
output
use
creat
rarefact
curv
show
flatten
curv
sequenc
supplementari
figur
alpha
divers
analysi
includ
rich
shannon
simpson
divers
indic
perform
use
mothur
softwar
statist
signific
differ
receiv
use
test
analysi
varianc
variabl
compris
group
aov
function
r
without
exclud
outlier
differ
rel
abund
measur
percentag
assess
parametr
test
analysi
varianc
nonparametr
mannwhitney
test
fisher
exact
test
use
preval
analysi
bacteri
famili
tabl
commun
comparison
done
use
nonmetr
multidimension
scale
nmd
adoni
function
vegan
packag
r
supplementari
method
nmd
analysi
nonparametr
ordinationbas
method
reduc
ecolog
commun
data
complex
identifi
meaning
relationship
among
commun
sociodemograph
clinic
characterist
infant
aom
control
includ
studi
describ
carnobacteriacea
enterobacteriacea
comamonadacea
tabl
male
infant
predomin
slightli
approxim
onequart
infant
aom
recent
expos
antimicrobi
approxim
onethird
attend
day
care
approxim
half
receiv
streptococcu
pneumonia
detect
cultur
half
infant
aom
control
composit
microbi
commun
sampl
determin
use
bidirect
pyrosequenc
target
variabl
region
rrna
gene
forward
sequenc
cluster
sequenc
ident
identifi
otu
median
number
otu
infant
aom
median
rang
significantli
lower
control
median
rang
p
median
shannon
divers
indic
includ
otu
rich
even
infant
aom
control
infant
p
therefor
infant
aom
microbiota
compris
fewer
otu
otu
less
evenli
distribut
control
otu
group
bacteri
famili
moraxellacea
present
np
specimen
streptococcacea
pasteurellacea
frequent
tabl
put
commens
famili
frequent
control
infant
aom
includ
staphylococcacea
fisher
exact
test
p
flavobacteriacea
p
carnobacteriacea
p
comamonadacea
p
infant
aom
recent
expos
antimicrobi
less
frequent
carri
streptococcacea
p
corynebacteriacea
p
frequent
carri
enterobacteriacea
p
without
exposur
addit
infant
aom
receiv
least
dose
less
frequent
carri
corynebacteriacea
p
nonvaccin
infant
map
show
preval
bacteri
famili
avail
supplementari
figur
moredetail
analysi
streptococcacea
hamper
fact
sequenc
discrimin
famili
use
cutoff
therefor
cultur
result
pneumonia
includ
tabl
control
approxim
onefifth
infant
aom
cultur
neg
pneumonia
carri
streptococcacea
p
recent
exposur
antimicrobi
associ
lower
preval
carriag
streptococcacea
includ
pneumonia
p
receipt
associ
reduc
preval
nonpneumococc
streptococcacea
p
next
rel
abund
bacteri
famili
sampl
determin
mean
standard
error
mean
calcul
compar
infant
aom
control
infant
aom
expos
antimicrobi
receiv
figur
moraxellacea
streptococcacea
pasteurellacea
tend
abund
infant
aom
control
although
differ
reach
statist
signific
figur
staphylococcacea
abund
control
infant
aom
p
bacteri
famili
classifi
other
none
reach
abund
infant
aom
healthi
control
famili
reach
abund
includ
comamonadacea
mainli
comamona
speci
acidaminococcacea
mainli
veillonella
speci
enterococcacea
mainli
enterococcu
speci
carnobacteriacea
mainli
granulicatella
speci
neisseriacea
mainli
neisseria
speci
use
mannwhitney
u
test
reveal
statist
signific
differ
among
staphylococcacea
p
comamonadacea
p
acidaminococcacea
p
corynebacteriacea
p
compar
preval
analysi
tabl
recent
exposur
antimicrobi
associ
increas
abund
pasteurellacea
p
furthermor
nonsignific
trend
lower
rel
abund
moraxellacea
streptococcacea
staphylococcacea
note
antimicrobi
exposur
group
figur
administr
associ
signific
increas
decreas
abund
bacteri
famili
figur
evalu
influenc
clinic
factor
pairwis
distanc
microbi
commun
per
sampl
measur
prevalencebas
unweight
abundancebas
weight
distanc
matric
use
input
amount
varianc
clinic
variabl
aom
antimicrobi
exposur
administr
contribut
calcul
unweight
analysi
nasopharyng
bacteri
commun
control
infant
aom
differ
significantli
p
figur
exclud
select
bia
time
analysi
also
perform
exclud
sampl
collect
prevaccin
season
similar
differ
receiv
p
data
shown
recent
exposur
antimicrobi
strongest
influenc
microbiota
infant
aom
p
figur
addit
administr
p
figur
sampl
prevaccin
versu
postvaccin
season
p
data
shown
slight
statist
signific
influenc
microbi
commun
factori
analysi
varianc
show
antimicrobi
act
independ
furthermor
age
sex
number
aom
episod
previou
month
day
care
use
influenc
univari
analysi
supplementari
tabl
use
weight
distanc
matric
reveal
signific
differ
infant
aom
control
p
none
factor
studi
shown
indic
differ
microbiota
base
discrep
relat
preval
bacteri
famili
unweight
analysi
rel
abund
weight
analysi
colon
densiti
estim
measur
dna
concentr
pcr
amplif
product
significantli
lower
dna
quantiti
observ
nasopharynx
control
median
valu
ngll
compar
infant
aom
ngll
p
addit
dna
quantiti
lower
microbi
commun
contain
pneumonia
streptococcacea
ngll
compar
cultur
posit
pneumonia
ngll
without
streptococcacea
ngll
p
result
suggest
invers
relationship
colon
densiti
otu
rich
statist
signific
differ
figur
comparison
bacteri
commun
nonmetr
multidimension
scale
nmd
ordin
plot
shown
result
infant
acut
otiti
media
aom
compar
control
infant
infant
aom
without
recent
antibiot
exposur
b
receipt
conjug
polysaccharid
vaccin
c
unweight
unifrac
distanc
matric
use
input
data
point
nmd
plot
repres
bacteri
commun
identifi
singl
nasopharyng
sampl
comparison
use
f
test
use
adoni
function
vegan
packag
yield
f
valu
p
b
p
c
p
p
valu
shown
absolut
valu
multipl
calcul
yield
slight
variat
found
stratifi
dna
concentr
clinic
variabl
age
sex
recent
antibiot
exposur
vaccin
studi
use
highthroughput
sequenc
analysi
nasopharyng
microbiota
infant
aom
control
infant
take
account
addit
host
factor
prior
exposur
antimicrobi
vaccin
statu
strength
analysi
homogen
studi
popul
restrict
infant
year
age
sampl
nasopharynx
larg
sampl
size
possibl
studi
influenc
clinic
variabl
microbi
commun
comparison
show
statist
signific
differ
infant
aom
control
infant
healthi
infant
microbiota
character
presenc
low
preval
bacteri
famili
nonpneumococc
streptococcacea
infant
aom
howev
classic
aom
pathogen
predomin
rare
put
commens
bacteri
famili
find
line
previou
report
use
cultureand
nonculturebas
method
examin
respiratori
tract
microbiota
suggest
richer
divers
microbiota
may
protect
aom
support
report
inhibitori
effect
ahemolyt
streptococci
colon
aom
pathogen
therebi
protect
recurr
aom
littl
known
epidemiolog
biolog
low
preval
bacteri
famili
live
nasopharynx
apart
involv
isol
case
aom
opportunist
infect
bloodstream
infect
associ
dental
procedur
recent
studi
investig
microbiota
healthi
infant
month
age
winter
summer
season
compar
control
studi
complex
divers
highli
variabl
microbiota
found
rel
lower
proport
aom
pathogen
moraxellacea
streptococcacea
pasteurellacea
compar
infant
aom
confirm
valid
control
group
show
independ
geograph
site
bacteri
famili
resid
nasopharynx
infant
modul
effect
antibiot
exposur
human
microbi
ecosystem
well
recogn
studi
recent
antimicrobi
treatment
strongest
factor
induc
bacteri
commun
chang
nasopharyng
microbiota
infant
aom
commun
structur
chang
toward
reduc
preval
commens
famili
streptococcacea
includ
pneumococci
corynebacteriacea
increas
preval
enterobacteriacea
greater
rel
abund
pasteurellacea
latter
observ
report
also
earlier
culturebas
studi
therefor
antimicrobi
chang
microbiota
toward
unhealthi
statu
lesser
presenc
commens
gener
effect
antibiot
exposur
microbiota
expect
depend
larg
preval
resist
gene
may
therefor
overrul
interspeci
relationship
may
lead
complex
unpredict
chang
microbiota
broad
use
parallel
shift
pneumococc
serotyp
distribut
unexpectedli
chang
preval
pathogen
resid
nasopharynx
individu
popul
level
studi
receiv
vaccin
sampl
obtain
introduct
chang
commun
structur
microbiota
toward
reduc
preval
commens
streptococcacea
exclud
pneumococci
corynebacteriacea
therefor
unexpectedli
result
indic
drive
microbiotia
toward
composit
lower
presenc
commens
mechan
mediat
influenc
clear
may
pneumococc
serotyp
emerg
select
pressur
inhibit
colon
commens
streptococcacea
serotyp
studi
influenc
age
histori
recurr
aom
sex
day
care
use
microbiota
observ
infant
aom
lack
associ
age
explain
narrow
age
rang
studi
sociodemograph
differ
switzerland
countri
may
reason
day
care
measur
influenc
microbiota
potenti
import
factor
could
concurr
infect
respiratori
viru
preliminari
studi
analyz
sampl
infant
aom
collect
presenc
rna
virus
includ
human
rhinoviru
respiratori
syncyti
viru
coronaviru
bocaviru
presenc
virus
effect
microbiota
either
preval
abund
bacteri
famili
data
present
agreement
preliminari
data
evid
associ
season
shift
microbiota
presenc
respiratori
virus
found
healthi
infant
netherland
howev
addit
studi
need
explor
role
virus
microbiota
detail
studi
limit
sampl
infant
aom
restrict
collect
winter
season
aom
incid
peak
winter
inform
diet
number
sibl
parent
smoke
may
influenc
microbiota
result
studi
may
therefor
appli
summer
season
shown
healthi
control
number
control
small
sampl
collect
rel
short
period
introduct
select
geograph
region
compar
sampl
infant
aom
howev
result
obtain
control
infant
resembl
close
describ
recent
dutch
studi
discuss
anoth
limit
studi
lack
highqual
quantit
data
colon
densiti
quantiti
bacteri
dna
np
specimen
small
imped
reliabl
quantif
microbiota
directli
sampl
howev
take
dna
concentr
pcr
amplif
product
surrog
colon
densiti
describ
reason
approach
result
suggest
colon
densiti
lower
bacteri
commun
increas
rich
healthi
microbiota
control
increas
quantiti
nontyp
h
influenza
pneumonia
catarrhali
observ
nasopharyng
secret
aom
compar
healthi
statu
therefor
pathogenesi
aom
may
includ
disturb
interspeci
balanc
ensu
overgrowth
aom
pathogen
conclus
studi
first
character
nasopharyng
microbiota
infant
without
aom
use
molecular
techniqu
key
find
character
microbiota
infant
aom
flora
reduc
rich
even
higher
colon
densiti
compar
healthi
control
infant
aom
recent
antimicrobi
exposur
influenc
commun
structur
microbiotia
toward
lower
preval
commens
bacteri
famili
especi
streptococcacea
corynebacteriacea
supplementari
materi
avail
journal
infecti
diseas
onlin
http
wwwoxfordjournalsorgourjournalsjid
supplementari
materi
consist
data
provid
author
publish
benefit
reader
post
materi
copyedit
content
supplementari
data
sole
respons
author
question
messag
regard
error
address
author
